Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Current Molecular Pharmacology|December 22, 2009
The effects of current therapies on airway remodeling in asthma and new possibilities for treatment and preventionS G Royce, M L K Tang
British Journal of Pharmacology|April 11, 2016
Combining an epithelial repair factor and anti-fibrotic with a corticosteroid offers optimal treatment for allergic airways diseaseK P Patel, A S Giraud, C S Samuel, et al.
Alimentary Pharmacology & Therapeutics|June 2, 2016
Allergy tests do not predict food triggers in adult patients with eosinophilic oesophagitis. A comprehensive prospective study using five modalitiesH Philpott, S Nandurkar, S G Royce, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|July 4, 2014
Risk factors for eosinophilic esophagitisH Philpott, S Nandurkar, S G Royce, et al.
Alimentary Pharmacology & Therapeutics|March 5, 2016
A prospective open clinical trial of a proton pump inhibitor, elimination diet and/or budesonide for eosinophilic oesophagitisH Philpott, S Nandurkar, S G Royce, et al.
Journal of Clinical Pathology|May 9, 2006
Liver fluke-associated and sporadic cholangiocarcinoma: an immunohistochemical study of bile duct, peribiliary gland and tumour cell phenotypesN R Hughes, C Pairojkul, S G Royce, et al.
Histochemistry and Cell Biology|October 29, 2000
Vertebrate phylogeny of antigen D10: identification of a conserved foregut cell lineageS G Royce, N R Hughes, S Binos, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 14, 2020
Hexarelin targets neuroinflammatory pathways to preserve cardiac morphology and function in a mouse model of myocardial ischemia-reperfusionH McDonald, J Peart, N D Kurniawan, et al.
British Journal of Pharmacology|June 3, 2016
Anti-fibrotic actions of relaxinC S Samuel, S G Royce, T D Hewitson, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|August 13, 2014
Intranasally administered serelaxin abrogates airway remodelling and attenuates airway hyperresponsiveness in allergic airways diseaseS G Royce, C X F Lim, K P Patel, et al.
Pageof 2